FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Bimagrumab Enhances Weight Loss: Study

New data from a Phase 2 study on Eli Lillys experimental bimagrumab showed that when combined with Novo Nordisk's Wegovy (semaglutide) it led to prese...

latest-news-card-1
Human Drugs

Guideline on Drug Stability Testing Released

FDA posts an International Council for Harmonization draft guideline entitled Stability Testing of Drug Substances and Drug Products Q1.

latest-news-card-1
Human Drugs

Inspections Help Prevent Drug Shortages: Study

A new study disputes previous assumptions about FDA inspections leading to more drug shortages at facilities receiving GMP citations.

latest-news-card-1
Human Drugs

Daiichi Sankyo Drug OKd for Lung Cancer

FDA approves a Daiichi Sankyo BLA for Datroway (datopotamab deruxtecan-dlnk) for certain adults with locally advanced or metastatic epidermal growth f...

latest-news-card-1
Human Drugs

Medline Issues Correction for Procedure Kits

Medline Industries recalls certain lots of its medical procedure kits that include recalled Medtronic Aortic Root Cannulas due to a potential safety r...

latest-news-card-1
Human Drugs

Dupixent Approved for Bullous Pemphigoid

FDA has approved Sanofi and Regenerons Dupixent (dupilumab) for treating adult patients with bullous pemphigoid that mainly affects the elderly with i...

latest-news-card-1
Human Drugs

Monjuvi Approved for Follicular Lymphoma

FDA approves Incytes Monjuvi (tafasitamab-cxix) in combination with lenalidomide and rituximab for treating adults with relapsed or refractory follicu...

Medical Devices

FDA Clears DeepEcho AI Fetal Ultrasound

FDA clears a DeepEcho 510(k) for its artificial intelligence-based fetal ultrasound analysis platform.

latest-news-card-1
Human Drugs

Cycles Harliku Approved for Alkaptonuria

FDA approves a Cycle Pharmaceuticals NDA for Harliku (nitisinone) tablets for reducing urine homogentisic acid in adult patients with alkaptonuria.

Medical Devices

Is FDA Going After RUO Diagnostics?

Two SheppardMullin attorneys say it remains to be seen whether a recent FDA Warning Letter to DRG Instruments about selling research-use-only (RUO) di...